Julia Szendrödi
Endocrinology — University Hospital Heidelberg, Germany
Julia Szendrödi
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Public Health - Nutrition
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2011 - 2026
Number : 105
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Tumor-Secreted ADAMTSL4 Activates Latent TGFβ1 to Drive Cancer Cachexia. muscular atrophy, cells, muscle cells, muscles, atrophy, fibrosis, neoplasms, therapeutics, cachexia, cancer-associated cachexia | Cancer Discov Top journal | 2026 | 1 |
| Effects of Gastric Bypass on Beta-cell function and Insulin sensitivity in Patients with Non-Severe Obesity (BMI<35 kg/m 2) and Insulin-treated Type 2 Diabetes. diabetes mellitus, cells, insulin, gastric bypass, obesity, obesity, morbid, diabetes mellitus, type 2 | Obes Surg | 2026 | 0 |
| Therapy of Type 2 Diabetes. diabetes mellitus, therapeutics, diabetes mellitus, type 2 | Exp Clin Endocrinol Diabetes | 2026 | 0 |
| [Prevention and precautions in the treatment of diabetes]. diabetes mellitus, internal medicine, prediabetic state, therapeutics | Inn Med (Heidelb) | 2026 | 0 |
| Nuclear receptor co-factor TBL1X/TBL1XR1 T cell activity protects against atherosclerosis. cytokines, cells, bone marrow, carotid arteries, arteries, atherosclerosis, t-lymphocytes, plaque, atherosclerotic | Mol Metab | 2026 | 0 |
Clinical Studies 6
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| SGLT2 inhibition in addition to lifestyle intervention and risk for complications in subtypes of patients with prediabetes a randomized placebo controlled multi center trial 2024-512179-11-00 — fasting, life style, glucose intolerance, multiple chronic conditions, prediabetic state | Phase 4 | Recruiting | 2023 |
| SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes NCT06054035 — diabetes mellitus, administration, oral, life style, healthy lifestyle, multiple chronic conditions, hyperglycemia, kidney, prediabetic state, diagnosis, therapeutics, renal insufficiency, diabetes mellitus, type 2 | Phase 4 | Recruiting | 2023 |
| Intermittent Fasting to Improve Insulin Secretion NCT04607096 — diabetes mellitus, cells, fasting, insulin, insulin secretion, diet, energy intake, prediabetic state, therapeutics, intermittent fasting | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map